logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David S. Miller

university of texas southwestern medical center
H指数:101
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估恶性腹水细胞学在子宫内膜癌中预后意义：一项NRG Oncology/妇科肿瘤学组关于GOG-210方案的研究

gynecologic oncology
IF4.1
2025-09-030
PRE
Koji Matsuo; Danielle M. Enserro; Jason D. Wright; Lynda D. Roman; Matthew A. Powell; David S. Miller; Christa I. Nagel; Premal H. Thaker; Robert S. Mannel; Ashley R. Stuckey; Saketh R. Guntupalli; Paniti Sukumvanich; Melissa A. Geller; Roberto Vargas; Gottfried E. Konecny; David P. Warshal; Krishnansu S. Tewari; Nick M. Spirtos; Bhavana Pothuri; William T. Creasman; David G. Mutch
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258

子宫内膜癌（EC）的分子分类及其与无复发生存期（RFS）和总生存期（OS）结局的关联：GOG-0258研究的附加分析

gynecologic oncology
IF4.1
2025-02-011
PRE
Clements, Aine; Enserro, Danielle; Strickland, Kyle C.; Previs, Rebecca; Matei, Daniela; Mutch, David; Powell, Matthew; Klopp, Ann; Miller, David Scott; Small Jr, William; Disilvestro, Paul; Spirtos, Nick; Cosgrove, Casey; Sfakianos, Greg; Liu, J. Rebecca; Vargas, Roberto; Shahin, Mark; Corr, Bradley; Dessources, Kimberly; Ueland, Frederick; Warshal, David; Gillen, Jessica; Secord, Angeles Alvarez
Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines

卵巢癌/输卵管癌/原发性腹膜癌，版本3.2024 NCCN指南重点更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-10-0115
PRE
Liu, Joyce; Berchuck, Andrew; Backes, Floor J.; Cohen, Joshua; Grisham, Rachel; Leath, Charles A., III; Martin, Lainie; Matei, Daniela; Miller, David S.; Robertson, Sharon; Barroilhet, Lisa; Uppal, Shitanshu; Hendrickson, Andrea Wahner; Gershenson, David M.; Gray, Heidi J.; Hakam, Ardeshir; Jain, Angela; Konecny, Gottfried E.; Moroney, John; Ratner, Elena; Schorge, John; Thaker, Premal H.; Werner, Theresa L.; Zsiros, Emese; Behbakht, Kian; Chen, Lee-May; Derosa, Marie; Eisenhauer, Eric L.; Leiserowitz, Gary; Litkouhi, Babak; Mchale, Michael; Percac-Lima, Sanja; Rodabaugh, Kerry; Vargas, Roberto; Jones, Frankie; Kovach, Emily; Hang, Lisa; Ramakrishnan, Swathi; Alvarez, Ronald D.; Armstrong, Deborah K.
Characterization of tumor response with lenvatinib plus pembrolizumab (LEN plus Pembro) in the ENGOT-en9/LEAP-001 study

ENGOT-en9/LEAP-001研究中lenvatinib联合pembrolizumab（LEN plus Pembro）对肿瘤反应的表征

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Danska-Bidzinska, A.; Makker, V.; Salutari, V.; Ayhan, A.; Romero, I.; Levy, T.; McCormack, M.; Baurain, J-F.; Mach, P.; Cadoo, K. A.; Mackay, H.; Friedlander, M. L.; Santin, A. D.; Slomovitz, B. M.; Miller, D. S.; McKenzie, J.; Yao, L.; Khemka, V.; Nogueira-Rodrigues, A.; Marth, C.
Global, phase Ib dose-expansion cohort of E7386+lenvatinib (LEN) in patients (pts) with advanced (a) endometrial cancer (EC) that progressed on platinum-based chemotherapy (CTx) and an anti-PD-(L)1 immunotherapy (IO)

全球、Ib期剂量扩展队列研究，评估E7386联合仑伐替尼（LEN）在既往接受过铂类化疗（CTx）及抗PD-(L)1免疫疗法（IO）治疗后进展的晚期（a）子宫内膜癌（EC）患者（pts）中的疗效。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lee, J-Y.; Hasegawa, K.; Kim, B-G.; Corr, B. R.; Kondo, S.; Suzuki, S.; Yunokawa, M.; Miller, D. S.; Tamai, T.; Dutta, L.; O'Hara, K.; Sahara, T.; Makker, V.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice

Lenvatinib联合Pembrolizumab治疗或医生选择治疗的晚期子宫内膜癌患者的健康相关生活质量

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-06-015
OAAI
Lorusso, Domenica; Colombo, Nicoletta; Herraez, Antonio Casado; Santin, Alessandro D.; Colomba, Emeline; Miller, David Scott; Fujiwara, Keiichi; Pignata, Sandro; Baron-Hay, Sally E.; Ray-Coquard, Isabelle Laure; Shapira-Frommer, Ronnie; Kim, Yong Man; Mccormack, Mary; Massaad, Rachid; Nguyen, Allison Martin; Zhao, Qi; Mckenzie, Jodi; Prabhu, Vimalanand S.; Makker, Vicky
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2023-01-013
PRE
Hammer, Liat; Jiang, Ralph; Hearn, Jason; Lashbrook, Jack; Mitchell, Amyre; Daignault-Newton, Stephanie; Dess, Robert T.; Jackson, William C.; Reichert, Zachery; Alumkal, Joshi J.; Kaffenberger, Samuel; George, Arvin; Montgomery, Jeffrey; Salami, Simpa S.; Morgan, Todd M.; Miller, David; Wittman, Daniela; Hollenbeck, Brent; Mehra, Rohit; Davenport, Matthew S.; Sun, Yilun; Schipper, Matthew; Palapattu, Ganesh; Spratt, Daniel E.
Updated efficacy and safety of lenvatinib (LEN) plus pembrolizumab (pembro) vs treatment of physician's choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775
ANNALS OF ONCOLOGY
IF65.4
2022-09-013
OAAI
Makker, V.; Colombo, N.; Casado Herraez, A.; Monk, B. J.; Mackay, H.; Santin, A. D.; Miller, D. S.; Moore, R. G.; Baron-Hay, S. E.; Ray-Coquard, I. L.; Shapira-Frommer, R.; Ushijima, K.; Yonemori, K.; Kim, Y. M.; Guerra Alia, E. M.; Sanli, U. A.; Huang, J.; McKenzie, J.; Barresi, G.; Lorusso, D.
Putting participants and study partners FIRST when clinical trials end early

当临床试验提前结束时，将参与者和研究伙伴放在首位

ALZHEIMERS & DEMENTIA
IF11.1
2022-08-025
OA
Largent, Emily A.; Walter, Sarah; Childs, Nancy; Dacks, Penny A.; Dodge, Shana; Florian, Hana; Jackson, Jonathan; Guerra, Jorge J. Llibre; Iturriaga, Erin; Miller, David S.; Moreno, Monica; Nosheny, Rachel L.; Obisesan, Thomas O.; Portacolone, Elena; Siddiqi, Bernadette; Silverberg, Nina; Warren, Rueben C.; Welsh-Bohmer, Kathleen A.; Edelmayer, Rebecca M.
Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L plus P) or treatment of physician's choice (TPC)
ANNALS OF ONCOLOGY
IF65.4
2022-06-010
OA
Lorusso, D.; Colombo, N.; Herraez, A. Casado; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; Shapira-Frommer, R.; Kim, Y. M.; McCormack, M.; Massaad, R.; Nguyen, A. Martin; Zhao, Q.; McKenzie, J.; Prabhu, V. S.; Makker, V.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-02-03498
OA
Makker, V; Colombo, N.; Casado Herraez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I; Shapira-Frommer, R.; Ushijima, K.; Sakata, J.; Yonemori, K.; Kim, Y. M.; Guerra, E. M.; Sanli, U. A.; McCormack, M. M.; Smith, A. D.; Keefe, S.; Bird, S.; Dutta, L.; Orlowski, R. J.; Lorusso, D.

研究方向

暂未获取到该数据
G
Gert Fricker
H 指数:63论文数:316被引数:1.3万
B
Björn Bauer
H 指数:38论文数:93被引数:7,871
A
Anika M. S. Hartz
H 指数:38论文数:80被引数:7,049
S
Sean M. Grimmond
H 指数:106论文数:548被引数:7.2万
R
Rosalinde Masereeuw
H 指数:62论文数:406被引数:1.3万
J
John B. Pritchard
H 指数:42论文数:122被引数:8,758
F
Frans G. M. Rüssel
H 指数:62论文数:406被引数:1.4万
J
Jayanthi Lea
H 指数:37论文数:315被引数:4,865
C
Christopher Campos
H 指数:19论文数:54被引数:1,482
M
María C. Carrillo
H 指数:76论文数:421被引数:7.8万